<DOC>
	<DOCNO>NCT00871234</DOCNO>
	<brief_summary>The purpose study determine safety effect etravirine , HIV antiretroviral medication , vascular function .</brief_summary>
	<brief_title>Effects Etravirine Endothelial Function HIV-uninfected Adults : A Pilot Study</brief_title>
	<detailed_description>We hypothesize HIV-uninfected subject , etravirine 200mg twice daily four week effect endothelial function . The primary objective study determine effect etravirine 200mg twice daily give four week endothelial function , measure flow-mediated dilation ( FMD ) brachial artery , HIV-uninfected subject . Secondary objective include determination effect etravirine 200mg twice daily give four week safety measure , lipid fraction , HOMA-IR , blood pressure , inflammatory parameter , endothelial activation parameter .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Etravirine</mesh_term>
	<criteria>1 . 18 year age old 2 . Negative ELISA HIV1 HIV2 screen 3 . Negative hepatitis B surface antigen screen 4 . Negative hepatitis C antibody screen 5 . For woman reproductive potential , negative urine pregnancy test screen willingness use two form birth control course study 6 . No history diabetes , hypertension , dyslipidemia 7 . No anticipated change addition medical therapy course study 1 . Inability provide write , inform consent 2 . Known allergy/intolerance etravirine nitroglycerin 3 . Absolute neutrophil count &lt; 750cell/mL screen 4 . Hemoglobin &lt; 11g/dL screen 5 . Platelet count &lt; 100,000/mL screen 6 . Estimated creatinine clearance ( per CockcroftGault equation ) &lt; 55 mL/min screen 7 . Liver transaminase ( AST ALT ) &gt; 100 IU/mL total bilirubin &gt; 1.5mg/dL screen 8 . Breastfeeding screen course study 9 . Hypotension , define SBP &lt; 90mmHg time main study visit brachial artery ultrasound measurements 10 . Receipt investigational agent , cytotoxic chemotherapy , systemic glucocorticoid ( &gt; 10mg/day prednisone equivalent ) , anabolic steroid within 30 day screen visit main study visit 11 . Use sildenafil ( Viagra Silagra ) , vardenafil ( Levitra ) , tadalafil ( Cialis ) , within 72 hour ( ) brachial artery reactivity test 12 . Indwelling vascular catheter within upper body vessel time brachial artery reactivity test 13 . Active drug alcohol use dependence , opinion investigator , would interfere adherence study requirement 14 . Acute therapy serious infection serious medical illness ( judgment site investigator ) require systemic treatment and/or hospitalization within 14 day prior screen study visit 15 . History migraine headache 16 . History Raynaud 's phenomenon 17 . History cardiac arrythmias 18 . History hypothyroidism hyperthyroidism untreated ( define TSH outside normal range recent test normal clinical care ) 19 . History carotid bruits . 20 . History tobacco use ( cigarette smoking , cigar smoking , chew tobacco ) nicotine replacement treatment ( patch , gum ) within one year screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>HIV</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Etravirine</keyword>
</DOC>